Results 31 to 40 of about 10,606 (259)

Complications and Outcomes of Impella Treatment in Cardiogenic Shock Patients With and Without Acute Myocardial Infarction

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, 2023
Background In patients with cardiogenic shock (CS), acute myocardial infarction (AMI) is the most common cause, and a percutaneous microaxial ventricular assist device (Impella, Abiomed, Danvers, MA) is a choice for temporary mechanical circulatory ...
Yuichi Saito   +4 more
doaj   +1 more source

Surgical embolectomy for acute massive pulmonary embolism: state of the art [PDF]

open access: yes, 2018
Massive pulmonary embolism (PE) is a severe condition that can potentially lead to death caused by right ventricular (RV) failure and the consequent cardiogenic shock.
De Bellis, Antonio   +8 more
core   +1 more source

Short‐term outcomes of heart transplant patients bridged with Impella 5.5 ventricular assist device

open access: yesESC Heart Failure, 2023
Aims We sought to investigate the outcomes of heart transplant patients supported with Impella 5.5 temporary mechanical circulatory support. Methods and results Patient demographics, perioperative data, hospital timeline, and haemodynamic parameters were
Osama Haddad   +10 more
doaj   +1 more source

Successful cases of percutaneous left ventricular assist device “Impella” to fulminant myocarditis

open access: yesJournal of Cardiothoracic Surgery, 2022
Background Fulminant myocarditis (FM) is a form of severe inflammatory carditis with rapidly developing acute heart failure. Case presentation We report three cases of successful intensive treatment by Impella of FM without any complications.
Takayuki Hori   +3 more
doaj   +1 more source

Impella-Induced Incessant Ventricular Tachycardia [PDF]

open access: yesOchsner Journal, 2019
Background: The Impella 2.5 and Impella Cardiac Power (CP) devices (ABIOMED) are used to provide mechanical circulatory support for high-risk percutaneous coronary interventions or cardiogenic shock as a bridge to recovery or destination therapy.
Reema Hasan   +7 more
openaire   +3 more sources

316: Diuretic is safe and superior to volume expansion in normotensive patients with acute pulmonary embolism and right ventricular dilatation [PDF]

open access: yes, 2013
BackgroundThe rational and the benefit of load expansion is controversial in acute pulmonary embolism (PE). Diuretic may reduce RV preload and improve hemodynamic status.
Dubois Randé, Jean-Luc   +6 more
core   +1 more source

Effect of Impella 5.5 on Preexisting Functional Mitral Regurgitation in Patients with Heart Failure–Related Cardiogenic Shock

open access: yesStructural Heart, 2022
Background: Heart failure–related cardiogenic shock (HF-CS) is increasingly common. Moderate/severe functional mitral regurgitation (FMR) is commonly seen in patients presenting with decompensated heart failure and is associated with worse outcomes ...
Rachna Kataria, MD   +8 more
doaj  

Impella as unloading strategy during VA-ECMO: systematic review and meta-analysis

open access: yesReviews in Cardiovascular Medicine, 2021
Veno-arterial extracorporeal membrane oxygenation (VA-ECMO) is used as mechanical circulatory support in cardiogenic shock (CS). It restores peripheral perfusion, at the expense of increased left ventricle (LV) afterload.
Francesca Fiorelli   +1 more
doaj   +1 more source

Pre-PCI versus immediate post-PCI Impella initiation in acute myocardial infarction complicated by cardiogenic shock.

open access: yesPLoS ONE, 2020
BackgroundIn selected patients with an acute myocardial infarction (AMI) complicated by Cardiogenic shock (CS), mechanical circulatory support with Impella may be beneficial, although conclusive evidence is still lacking.
Veemal V Hemradj   +17 more
doaj   +1 more source

Prophylactic Impella CP versus VA-ECMO in Patients Undergoing Complex High-Risk Indicated PCI

open access: yesJournal of Interventional Cardiology, 2022
Objectives. To compare two different forms of mechanical circulatory support (MCS) in patients with complex high-risk indicated PCI (CHIP): the Impella CP system and veno-arterial extracorporeal membrane oxygenation (VA-ECMO). Background.
Deborah M.F. van den Buijs   +10 more
doaj   +1 more source

Home - About - Disclaimer - Privacy